Neuropilin function in developmental and tumor angiogenesis
Neuropilin function in developmental and tumor angiogenesis
批准号:
6668225
负责人:
MICHAEL KLAGSBRUN
金额:
$9.16万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2003-08-31
关键词:
SCID mouse angiogenesis angiogenesis factor angiogenesis inhibitors antisense nucleic acid cell communication molecule cell growth regulation cell line growth factor receptors membrane proteins metastasis neoplasm /cancer blood supply neoplastic growth nonmammalian vertebrate embryology protein isoforms protein structure function receptor binding receptor expression tissue /cell culture vascular endothelial growth factors zebrafish
中文摘要
NRP1和NRP2是VEGF和3A类信号蛋白的细胞表面受体。NRPs是发育中的小鼠胚胎正常血管生成和血管生成所必需的。NRPs由肿瘤细胞表达并结合VEGF。NRP1在肿瘤细胞中的诱导表达可能以vegf依赖的方式促进肿瘤血管生成和肿瘤进展。另一方面,信号蛋白可能是肿瘤拮抗剂。Sema3A抑制体外血管生成,在前列腺肿瘤中的初步结果表明,Sema3F在转移性病变中不存在。建议将这些研究扩展到新的方向,重点放在体内实验上。在第一个目标中,将在斑马鱼中探索发育血管生成,这是一个研究发育过程的优秀系统,从胚胎开始
英文摘要
NRP1 and NRP2 are cell surface receptors for VEGF and class 3A semaphorins. NRPs are necessary for normal vasculogenesis and angiogenesis in the developing mouse embryo. NRPs are expressed by tumor cells and bind VEGF. Inducible expression of NRP1 in tumor cells enhances tumor angiogenesis and tumor progression, possibly in a VEGF-dependent manner. On the other hand, semaphorins may be tumor antagonists. Sema3A inhibits in vitro angiogenesis, and preliminary results in prostate tumors indicate that Sema3F is absent in metastatic lesions. It is proposed to expand these studies in new directions with an emphasis on in vivo experimentation. In the first aim, developmental angiogenesis will be explored in the zebrafish, an excellent system for studying developmental processes, since embryonic
development is rapid, the embryos are transparent, and 100-200 eggs are laid outside of the organism, allowing ready and statistical manipulation of the embryos, in preliminary studies, zebrafish NRP1 (zNRP) has been cloned. Antisense morpholino oligonuceotides that block zNRP1 synthesis result in cardiovascular anomalies. It is proposed to continue these functional studies and to extend them to NRP2, other VEGF family members that bind to NRPs (PIGF VEGF-B and VEGF-E), other angiogenesis factors and angiogenesis inhibitors. In the second aim the function of NRPs and semaphorins in tumors will be analyzed in vivo. Since Sema 3F is down-regulated in metastatic lesions, it will be overexpressed in highly metastatic tumor cells and analyzed for effects on tumor growth, tumor angiogenesis and metastasis. So will Sema3A. The overall goal is to delineate the function of NRPs and their ligands in developmental and tumor angiogenesis, processes which may have molecular properties in common. Our Specific Aims are: 1) To analyze the function of neuropilins and their ligands in a zebrafish model of developmental angiogenesis; 2) To analyze the function of neuropilins and semaphorins in mouse models
of tumor angiogenesis and metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuropilin and Semaphorin Function in Development and Tumor Angiogenesis
-
批准号:7313774
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2007
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
CHARACTERIZATION AND ISOLATION OF A NOVEL VEGF RECEPTOR
-
批准号:6443843
-
项目类别:
-
资助金额:$9.16万
-
财政年份:2001
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
CHARACTERIZATION AND ISOLATION OF A NOVEL VEGF RECEPTOR
-
批准号:6344719
-
项目类别:
-
资助金额:$20.9万
-
财政年份:2000
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
CHARACTERIZATION AND ISOLATION OF A NOVEL VEGF RECEPTOR
-
批准号:6102405
-
项目类别:
-
资助金额:$20.9万
-
财政年份:1999
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
CHARACTERIZATION AND ISOLATION OF A NOVEL VEGF RECEPTOR
-
批准号:6269301
-
项目类别:
-
资助金额:$20.38万
-
财政年份:1998
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
CHARACTERIZATION AND ISOLATION OF A NOVEL VEGF RECEPTOR
-
批准号:6236926
-
项目类别:
-
资助金额:$21.61万
-
财政年份:1997
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
Circulating Inhibitors of Endothelial Cell Growth
-
批准号:7348329
-
项目类别:
-
资助金额:$31.11万
-
财政年份:1995
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:2415160
-
项目类别:
-
资助金额:$27.24万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN-BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:3306885
-
项目类别:
-
资助金额:$24.45万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HB-EGF AND ITS RECEPTORS
-
批准号:6519487
-
项目类别:
-
资助金额:$28.31万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HB-EGF AND ITS RECEPTORS
-
批准号:6651992
-
项目类别:
-
资助金额:$28.31万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN-BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:2184810
-
项目类别:
-
资助金额:$25.76万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:2701556
-
项目类别:
-
资助金额:$28.1万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN-BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:3306884
-
项目类别:
-
资助金额:$25.7万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HB-EGF AND ITS RECEPTORS
-
批准号:6287223
-
项目类别:
-
资助金额:$28.31万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN-BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:2184809
-
项目类别:
-
资助金额:$24.89万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:2184811
-
项目类别:
-
资助金额:$26.42万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HB-EGF AND ITS RECEPTORS
-
批准号:6386296
-
项目类别:
-
资助金额:$28.31万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
HEPARIN BINDING EGF--STRUCTURE AND FUNCTION
-
批准号:2910093
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1992
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
THE CHEMISTRY AND BIOLOGY OF THE FGF
-
批准号:3434164
-
项目类别:
-
资助金额:$0.3万
-
财政年份:1991
-
负责人:MICHAEL KLAGSBRUN
-
依托单位:
国内基金
海外基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位: